Detalhe da pesquisa
1.
Comparison of a Novel Human Rabies Monoclonal Antibody to Human Rabies Immunoglobulin for Postexposure Prophylaxis: A Phase 2/3, Randomized, Single-Blind, Noninferiority, Controlled Study.
Clin Infect Dis;
66(3): 387-395, 2018 01 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29020321
2.
An observer-blind, randomised, placebo-controlled, phase 1, single ascending dose study of dengue monoclonal antibody in healthy adults in Australia.
Lancet Infect Dis;
24(6): 639-649, 2024 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38408457
3.
Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults.
Hum Vaccin Immunother;
20(1): 2304974, 2024 Dec 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38512394
4.
Active safety surveillance of rabies monoclonal antibody and rabies vaccine in patients with category III potential rabies exposure.
Lancet Reg Health Southeast Asia;
14: 100207, 2023 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37492421
5.
Post-marketing safety surveillance of the rotavirus vaccine in India.
Vaccine X;
15: 100362, 2023 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37593522
6.
A Phase 1, double-blind, randomized, placebo-controlled study to evaluate the safety and immunogenicity of a tetravalent live attenuated dengue vaccine in adults.
Vaccine;
41(38): 5614-5621, 2023 08 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37532611
7.
Safety and Immunogenicity of SARS-CoV-2 Recombinant Spike Protein Vaccine in Children and Adolescents in India: A Phase 2-3 Randomized Clinical Trial.
JAMA Pediatr;
2023 Jul 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37523166
8.
A Phase 3, randomized, non-inferiority study of a heterologous booster dose of SARS CoV-2 recombinant spike protein vaccine in adults.
Sci Rep;
13(1): 16579, 2023 10 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37789040
9.
Safety and immunogenicity of SII-NVX-CoV2373 (COVID-19 vaccine) in adults in a phase 2/3, observer-blind, randomised, controlled study.
Lancet Reg Health Southeast Asia;
10: 100139, 2023 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36647543
10.
A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in India.
EClinicalMedicine;
42: 101218, 2021 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34870133
11.
Safety, immunogenicity and lot-to-lot consistency of a new Bivalent Oral Polio Vaccine (bOPV) in healthy Infants: Results of a Phase III, observer blind, randomized, controlled clinical study.
Vaccine;
37(31): 4275-4280, 2019 07 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31235374
12.
Clinical study of safety and immunogenicity of pentavalent DTP-HB-Hib vaccine administered by disposable-syringe jet injector in India.
Contemp Clin Trials Commun;
14: 100321, 2019 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30899835
13.
A Phase III open-label, randomized, active controlled clinical study to assess safety, immunogenicity and lot-to-lot consistency of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants.
Vaccine;
36(52): 7943-7949, 2018 12 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30420116
14.
Non-interference of Bovine-Human reassortant pentavalent rotavirus vaccine ROTASIIL® with the immunogenicity of infant vaccines in comparison with a licensed rotavirus vaccine.
Vaccine;
36(37): 5519-5523, 2018 09 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30104114
15.
Development of a new purified vero cell rabies vaccine (Rabivax-S) at the serum institute of India Pvt Ltd.
Expert Rev Vaccines;
16(4): 303-311, 2017 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28276304
16.
Seroprevalence of Measles, Mumps, and Rubella Antibodies in College Students in Mumbai, India.
Viral Immunol;
29(3): 159-63, 2016 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26910764
17.
A randomized non-inferiority clinical study to assess post-exposure prophylaxis by a new purified vero cell rabies vaccine (Rabivax-S) administered by intramuscular and intradermal routes.
Vaccine;
34(40): 4820-6, 2016 09 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27554534
18.
Corrigendum to "Safety, immunogenicity and lot-to-lot consistency of a new Bivalent Oral Polio Vaccine (bOPV) in healthy Infants: Results of a Phase III, observer blind, randomized, controlled clinical study" [Vaccine 37 (2019) 4275-4280].
Vaccine;
38(3): 707-708, 2020 Jan 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31848050
19.
Safety and immunogenicity of dry powder measles vaccine administered by inhalation: a randomized controlled Phase I clinical trial.
Vaccine;
32(50): 6791-7, 2014 Nov 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25446830
20.
Response to: Letter from P. Gillard and B. Benninghoff.
Vaccine;
37(23): 2991-2992, 2019 05 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31072468